Evidence map›Paper›PMID 27382275›Full record

ReviewInternational journal of chronic obstructive pulmonary disease2016

Lung inflammation caused by inhaled toxicants: a review.

John Wong, Bruce E Magun, Lisa J Wood

Open access · goldAbstract readReview
In one paragraph

Review in International journal of chronic obstructive pulmonary disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 2 pooled it
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 2 syntheses or guidelines pooled it, 185 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Targeting neutrophil serine proteases in bronchiectasis.The European respiratory journal · 2025
    Review
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

John WongSchool of Nursing, MGH Institute of Health Professions, Boston, MA, USA.
Bruce E MagunSchool of Nursing, MGH Institute of Health Professions, Boston, MA, USA.
Lisa J WoodSchool of Nursing, MGH Institute of Health Professions, Boston, MA, USA.
MGH Institute of Health Professions · US

Funding

Targeting IL-1beta as a strategy for symptom control in cancerR01NR013171 · NINR · MGH INSTITUTE OF HEALTH PROFESSIONS · PI MAGUN, BRUCE E., WOOD MAGEE, LISA J · 2012 to 2015
$1.6M
NINR NIH HHS R01 NR013171
6 · The paper itself

Abstract

Exposure of the lungs to airborne toxicants from different sources in the environment may lead to acute and chronic pulmonary or even systemic inflammation. Cigarette smoke is the leading cause of chronic obstructive pulmonary disease, although wood smoke in urban areas of underdeveloped countries is now recognized as a leading cause of respiratory disease. Mycotoxins from fungal spores pose an occupational risk for respiratory illness and also present a health hazard to those living in damp buildings. Microscopic airborne particulates of asbestos and silica (from building materials) and those of heavy metals (from paint) are additional sources of indoor air pollution that contributes to respiratory illness and is known to cause respiratory illness in experimental animals. Ricin in aerosolized form is a potential bioweapon that is extremely toxic yet relatively easy to produce. Although the aforementioned agents belong to different classes of toxic chemicals, their pathogenicity is similar. They induce the recruitment and activation of macrophages, activation of mitogen-activated protein kinases, inhibition of protein synthesis, and production of interleukin-1 beta. Targeting either macrophages (using nanoparticles) or the production of interleukin-1 beta (using inhibitors against protein kinases, NOD-like receptor protein-3, or P2X7) may potentially be employed to treat these types of lung inflammation without affecting the natural immune response to bacterial infections.

Indexed as

Air MicrobiologyLungPneumoniaAnimalsEnvironmental PollutantsHost-Pathogen InteractionsHumansInhalation ExposureMycotoxinsRicinRisk AssessmentRisk FactorsSignal TransductionSmokeSmokingEnvironmental PollutantsMycotoxinsRicinSmokecigaretteinflammasomeinhibitorsmacrophagemycotoxinricintrichothecene

Identifiers

PMID27382275
PMCPMC4922809
OpenAlexW2469531838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.